Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2591-2600 Newer>

BusinessWeek January 9, 2006 Michael Arndt	Dr. Todd A. Kuiken: Bionic Sensation Dr. Todd A. Kuiken's training in engineering and medicine helps him build some of the best robotic limbs.
BusinessWeek January 9, 2006 Carol Matlack	Preventing The Pandemic France's Sanofi Pasteur is already signing contracts for an avian flu vaccine.
ifeminists December 28, 2005 Tony Zizza	If Depression Hurts, Eli Lilly Is Killing Us Eli Lilly's latest marketing campaign is a form of propaganda that speaks to how low Big Pharma will go to keep Americans in chemical handcuffs.
The Motley Fool December 28, 2005 Stephen D. Simpson	AstraZeneca, Reloaded In an attempt to shore up a soft pipeline, AstraZeneca has gotten very busy looking for partners. Investors, this is not the most attractive stock in the sector, but not a horrible pick, either.
National Defense January 2006 Robert H. Williams	Sport Body Fuel Drink Takes Edge Off Thirst British troops in hot, arid climes now have another means to avoid dehydration through a GlaxoSmithKline and QinetiQ effort.
The Motley Fool December 27, 2005 Jack Uldrich	Nucryst's Nano IPO Could Burn Investors Investors in this pharmaceutical should proceed with great caution because they risk getting burned from this IPO.
The Motley Fool December 22, 2005 Karl Thiel	The Skinny on Obesity Drugs Drug companies are working on novel new ways to battle the bulge. Which pharmas' efforts might fatten your portfolio?
Fast Company December 2005	Brilliant Biotech Our Innovation Scorecard takes a look at biotechnology, one of the hottest industries around, and comes up with four companies to watch.
The Motley Fool December 21, 2005 Stephen D. Simpson	Biomet Takes a Bum Knee Company excuses aside, a subpar quarter lends credence to the notion that orthopedics companies are still in a tough spot. Investors, take note.
The Motley Fool December 19, 2005 Brian Gorman	Developing Drug Markets Drug companies focusing on the developing world could see major payoffs. Asia, Africa, and Australia offer very significant opportunities for investors.
<Older 2591-2600 Newer> Return to current articles.